NCT07128953

Brief Summary

This study adopted a randomized, double-blind, placebo-controlled clinical trial design to evaluate the efficacy and safety of Zuoqing San fumigation and washing on the wound healing after anal fistula surgery.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P75+ for early_phase_1

Timeline
Completed

Started Aug 2025

Shorter than P25 for early_phase_1

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 17, 2025

Completed
15 days until next milestone

Study Start

First participant enrolled

August 1, 2025

Completed
1 day until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 2, 2025

Completed
17 days until next milestone

First Posted

Study publicly available on registry

August 19, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2026

Completed
Last Updated

August 19, 2025

Status Verified

August 1, 2025

Enrollment Period

1 day

First QC Date

July 17, 2025

Last Update Submit

August 18, 2025

Conditions

Keywords

Anal fistula

Outcome Measures

Primary Outcomes (1)

  • Wound healing time

    The number of days from the day after the operation until the wound surface is completely covered by epithelium (as observed by the naked eye, there is no exudation, and upon palpation, the scar is smooth).

    From postoperative day 1 until wound healing is achieved (assessed daily during hospitalization and weekly after discharge, up to 8 weeks)

Study Arms (2)

Study Group

EXPERIMENTAL

ZQS

Drug: Solution of Zuoqing San for fumigation and washing of the postoperative wound of anal fistula

control Group

PLACEBO COMPARATOR

Control

Other: Equal-volume placebo inhalation rinse

Interventions

Left Qing San Decoction (25g of Cai Yin + 30g of Eucommia + 25g of Sophora flavescens + 25g of Anemarrhena asphodeloides + 15g of Lithospermum erythrorhizon, prepared in the Pharmacy Department of Anhui University of Traditional Chinese Medicine), add 1000mL of water, boil, then steam and wash the wound surface. The temperature is 40 ± 2℃. Do it once a day, for 15 minutes each time, for 7 consecutive days.

Study Group

Equal-volume placebo inhalation rinse

control Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Recurrent swelling and pain, along with pus discharge around the anus;
  • Preoperative MRI or ultrasound confirmed the presence of the fistula;
  • Underwent incision of the anal fistula, with the postoperative wound diameter ranging from 2 to 4 cm.

You may not qualify if:

  • Inflammatory bowel disease (such as Crohn's disease) related anal fistula;
  • Complicated with severe dysfunction of heart, liver and kidney (ALT/AST \> 2 times upper limit, Cr \> 1.5 mg/dL);
  • Pregnant or lactating women;
  • Those who are known to be allergic to the components of Zuoqing San;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Anhui university of Chinese Medicine

Hefei, Anhui, 230000, China

Location

MeSH Terms

Conditions

Rectal Fistula

Interventions

Fumigation

Condition Hierarchy (Ancestors)

Intestinal FistulaDigestive System FistulaDigestive System DiseasesIntestinal DiseasesGastrointestinal DiseasesRectal DiseasesFistulaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Communicable Disease ControlPublic Health PracticePublic HealthEnvironment and Public Health

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Inclusion criteria\*\* 1\. \*\*Western medical diagnostic criteria\*\* (refer to "Surgery for Anorectal Diseases" 2018 edition): * History of recurrent swelling and pus discharge around the anus; * Confirmed presence of fistula through preoperative MRI or ultrasound; * Undergone incisional surgery for anal fistula, with postoperative wound diameter ranging from 2 to 4 cm.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
The First Affiliated Hospital of Anhui University of Chinese Medicine

Study Record Dates

First Submitted

July 17, 2025

First Posted

August 19, 2025

Study Start

August 1, 2025

Primary Completion

August 2, 2025

Study Completion

February 1, 2026

Last Updated

August 19, 2025

Record last verified: 2025-08

Locations